Profile
Paul J.
Carter worked as a Founding Director at Immunex Corp.
from 2000 to 2002.
He then worked as a Research Director at Amgen, Inc. in 2003.
From 2003 to 2008, he worked as a Vice President at Seagen Inc. He also served as the Chief Scientific Officer at Viral Logic Systems Technology Corp.
Dr. Carter received his undergraduate degree in 1982 and his doctorate in 1986 from the University of Cambridge.
Former positions of Paul J. Carter
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 2007-12-31 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | 2001-12-31 |
Viral Logic Systems Technology Corp.
 Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - |
Training of Paul J. Carter
| University of Cambridge | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 3 |
|---|---|
Viral Logic Systems Technology Corp.
Viral Logic Systems Technology Corp. Pharmaceuticals: MajorHealth Technology Viral Logic Systems Technology Corp. provides pharmaceutical products and services. It develops treatments for autoimmune, inflammatory diseases and disorders. The company was founded by Steven R. Wiley and Craig A. Smith in 2004 and headquartered in Seattle, WA. | Health Technology |
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
- Stock Market
- Insiders
- Paul J. Carter
